Distributor Analysis in Nigeria
Frost & Sullivan, December 2010, Pages: 85
Distributor Analysis in Nigeria provides a detailed analysis of the distribution landscape in the Nigerian healthcare industry. The research service analyses Nigeria's healthcare environment, focusing on pharmaceuticals and medical device segments. The pharmaceutical market is further segmented into generic and branded drug segments. For each of these segments, market revenue forecasts are provided from 2009 up to 2016. The core of the research is a thorough analysis of the distribution landscape, specifically examining the distribution structure and channel, distribution challenges, regulatory requirements, key distribution trends and company profiles of key distributors.
This research service titled Distributor Analysis in Nigeria provides an analysis of the pharmaceutical distribution landscape in Nigeria, and company profiles of major distributors. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: pharmaceuticals and medical devices.
Market Overview:
Improved Regulatory Environment to Promote Expansion of the Nigerian Pharmaceutical Market
The informal sector in Nigeria is one of the chief sources of drugs for retail businesses for resell to end-users. Despite the surge in informal trade in recent years, the formal sector however remains the most important channel of supply. In the past, the lack of appropriate regulations and enforcement has fuelled concerns about the quality and legitimacy of products, thus affecting all drug suppliers including formal distributors and suppliers. This is however poised to change in future with the improving regulatory environment.
“Growth in the pharmaceutical market is expected to be driven by the increasing availability of low-cost generic drugs and an improving regulatory system,” notes the analyst of this research. An improved regulatory system is anticipated to boost uptake of drugs by inspiring end-user confidence and eliminating competition from illegal imports and sub-standard products.
Leakage of Supply into Informal Sector presents Key Challenge:
The leakage of supply into the informal sector has been a key challenge for manufacturers as quality assurance mechanisms cannot be enforced. These include monitoring of storage conditions and product expiration - all factors that affect treatment outcomes. As the informal sector is very important source of drugs for retail businesses, it has affected customer confidence in some pharmacies and distributors. “Although it is difficult to regulate the informal sector adequately, the regulatory agency, NAFDAC, has been making considerable progress in reducing the problem of sub-standard and illegal products,” remarks the analyst. “Recent interventions which include the introduction of the Drug Distribution Inspection Committee (DDIC) will improve enforcement through regular inspection of documentation throughout the supply chain.”
Through vertical integration, manufacturers in Nigeria are now moving into distribution, and gaining greater control of the supply chain. The major manufacturers in the country are setting up their own distribution subsidiaries that distribute directly to retail pharmacies and patent medicine vendors (PMVs).
“Since PMVs are more likely to purchase supplies through the informal sector, supplier relationship with these outlets has to improve through education and training,” advises the analyst.
Market Sectors:
Expert Frost & Sullivan analysts thoroughly examine the following segments in this research:
- Pharmaceuticals
- Medical devices
1. Executive Summary
2. Research Aim and Objectives
3. Research Scope, Definitions and Exchange Rate
4. Research Methodology
5. Healthcare Industry Overview
5.1 Introduction and Overview
5.2 Pharmaceutical Industry Overview
5.3 Medical Device Industry Overview
6. Distribution Channel Analysis
6.1 Introduction and Overview
6.2 Structure of the Distribution Channel
6.3 Distribution Channel Trends
6.4 Industry Challenges
7. Profiles of Key Distributors
8. About Frost & Sullivan
List of Figures:
Healthcare Industry: Impact of Top Three Industry Challenges (Nigeria), 2009-2016
Healthcare Industry: Exchange Rates (Nigeria), 2009
Healthcare Industry: Health Indicators (Nigeria), 2009
Healthcare Industry: Importation of Pharmaceutical Products (Nigeria), 2009
Pharmaceutical Industry: Competitive Structure (Nigeria), 2009
Medical Device Industry: Competitive Structure (Nigeria), 2009
Healthcare Industry: Distribution Metrics (Nigeria), 2009
Healthcare Industry: Key Trends Shaping Distribution Landscape (Nigeria), 2009
Healthcare Industry: Impact of Top Five Industry Challenges (Nigeria), 2009
List Of Charts:
Healthcare Industry: Market Segmentation (Nigeria), 2009
Healthcare Industry: Market Forecasts (Nigeria), 2009 and 2016
Healthcare Industry: Distribution Channel Structure (Nigeria), 2009
Healthcare Industry: Purchasing Criteria (Nigeria), 2009
Healthcare Industry: SWOT Analysis (Nigeria), 2009
Pharmaceutical Industry: Market Segmentation (Nigeria), 2009
Pharmaceutical Industry: Market Shares of Main Exporters (Nigeria), 2009
Pharmaceutical Industry: Market Engineering Measurements (Nigeria), 2009
Pharmaceutical Industry: Market Drivers and Restraints (Nigeria), 2010-2016
Pharmaceutical Industry: Revenue Forecasts (Nigeria), 2009 and 2016
Medical Device Industry: Market Segmentation (Nigeria), 2009
Medical Device Industry: Market Share by Product Class (Nigeria), 2009
Medical Device Industry: Market Engineering Measurements (Nigeria), 2009
Medical Device Market: Market Drivers and Restraints (Nigeria), 2010-2016
Medical Device Market: Revenue Forecasts (Nigeria), 2009 and 2016
Healthcare Industry: Distribution Channel Structure (Nigeria), 2009
Product Samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network